
News – Page 7
-
Paraquat Lawsuits Filed Over Link to Parkinson’s DiseaseThe popular herbicide paraquat has been used on crops in the United States since the 1960s, but lawsuits say exposure to the toxic…
-
FDA Warns of Heart Problems and Cancer with Arthritis Drug XeljanzThe arthritis and ulcerative colitis drug Xeljanz (tofacitinib) could potentially increase the risk of heart-related problems and cancer, according to a February 2021…Michelle Llamas, BCPA April 5, 2021
-
Analysis: Zantac May Form High Levels of Toxic NDMA in the BodyAn analysis published in the Journal of the American Medical Association (JAMA) Network Open, suggests Zantac and drugs containing ranitidine may cause high…Michelle Llamas, BCPA March 22, 2021
-
Adverse Drug Events: What Consumers Need to KnowIn 2019, pharmacies filled an estimated 4.38 billion prescriptions. When you pick up your medication, it comes with a paper or booklet containing…Rachel Brummert March 22, 2021
-
AFFF Firefighting Foam Lawsuits Filed Over Cancer RiskA growing number of firefighters have filed lawsuits that claim toxic chemicals in AFFF firefighting foam caused them to develop cancer, according to…Michelle Llamas, BCPA February 22, 2021
-
Eisai Loses Motion to Dismiss Design Defect Claim in Belviq Cancer LawsuitEisai Inc. and Arena Pharmaceuticals Inc. failed to get design defect claims dismissed in a lawsuit that alleges the weight loss drug Belviq…Michelle Llamas, BCPA February 8, 2021
-
Cancer & COVID-19 Risk: A Q&A with Dr. Gary LymanAnyone exposed to COVID-19 is at risk of infection, but people with cancer are at increased risk of infection, severe complications and death…Michelle Llamas, BCPA February 8, 2021
-
Health Care Professionals Join Drugwatch.com’s Network of ExpertsDrugwatch.com is excited to announce the addition of three respected health care professionals to our network of expert contributors. Along with Drugwatch’s other…Michelle Llamas, BCPA February 1, 2021
-
Drugwatch Writer Joins COVID-19 Press Teleconference Advisory BoardDrugwatch’s senior writer Michelle Llamas has joined the National Center for Health Research’s PCORI COVID-19 Press Teleconference Advisory Board. The…Sophia Clifton January 28, 2021
Who Am I Calling?
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
(888) 645-1617